Insider Selling: Howard Donnelly Sells 20,000 Shares of AngioDynamics Stock (ANGO)
AngioDynamics (NASDAQ:ANGO) Director Howard Donnelly unloaded 20,000 shares of AngioDynamics stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $15.06, for a total value of $301,200.00. Following the transaction, the director now directly owns 15,850 shares in the company, valued at approximately $238,701. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Canaccord Genuity raised their price target on shares of AngioDynamics from $11.50 to $13.00 in a research note to investors on Friday, October 11th. They now have a “hold” rating on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of AngioDynamics in a research note to investors on Tuesday, October 1st. They now have a $14.00 price target on the stock.
Shares of AngioDynamics (NASDAQ:ANGO) traded up 0.66% during mid-day trading on Monday, hitting $15.35. The stock had a trading volume of 121,203 shares. AngioDynamics has a 1-year low of $9.52 and a 1-year high of $15.36. The stock’s 50-day moving average is $12.81 and its 200-day moving average is $11.51. The company’s market cap is $538.6 million.
AngioDynamics (NASDAQ:ANGO) last announced its earnings results on Thursday, October 10th. The company reported $0.04 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.03 by $0.01. The company had revenue of $83.60 million for the quarter, compared to the consensus estimate of $82.54 million. During the same quarter in the prior year, the company posted $0.10 earnings per share. The company’s quarterly revenue was up .2% on a year-over-year basis. On average, analysts predict that AngioDynamics will post $0.34 earnings per share for the current fiscal year.
AngioDynamics, Inc designs manufacture and sell a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.